secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tyra Biosciences, Inc. (TYRA)
CIK:        0001863127
Form:       8-K
Filed at:   2024-02-05T23:59:59+00:00
Accession:  0001193125-24-023367
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tyra Biosciences announces $200M private placement led by RA Capital at $13.01/share
--------------------------------------------------------------------------------

- Gross proceeds of approximately $200 million from sale of ~15.4 million shares/pre-funded warrants at $13.01 per share.
- Financing led by RA Capital Management with participation from Boxer Capital, BVF Partners, Nextech, OrbiMed, 5AM Ventures.
- Proceeds to advance clinical development of TYRA-300 and TYRA-200, preclinical programs, and for working capital.
- PIPE expected to close on February 6, 2024, subject to customary closing conditions.
- Company to file resale registration statement with SEC within 45 days after closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1863127/000119312524023367/0001193125-24-023367-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1863127/000119312524023367/d620082d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-023367

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer